Expression of excision repair cross-complementation group 1 (ERCC1), ribonucleotide reductase M1 (RRM1) and class III beta-tubulin in head and neck carcinoma and its clinical significance.

Conclusions:Unlike lung carcinoma, expression of ERCC1 or RRM1 did not correlate with clinical parameters or HPV status. However, p16 and TUBB3 might be useful predictive biomarkers in HNCa.

http://www.oapublishinglondon.com/article/455

Source: Head and Neck Oncology - February 13, 2015 Category: Cancer & Oncology Source Type: research